OpenURL Connection Search

Select item for more details and to access through your institution.

Phase 1b study of intravenous coxsackievirus A21 (V937) and ipilimumab for patients with metastatic uveal melanoma.
Published in:
Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6059, doi. 10.1007/s00432-022-04510-3
By:
- Lutzky, Jose;
- Sullivan, Ryan J.;
- Cohen, Justine V.;
- Ren, Yixin;
- Li, Anlong;
- Haq, Rizwan
Publication type:
Article
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma.
Published in:
Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 3, p. 439, doi. 10.1007/s00432-016-2318-x
By:
- Atkinson, Thomas;
- Hay, Jennifer;
- Shoushtari, Alexander;
- Li, Yuelin;
- Paucar, Daniel;
- Smith, Sloane;
- Kudchadkar, Ragini;
- Doyle, Austin;
- Sosman, Jeffrey;
- Quevedo, Jorge;
- Milhem, Mohammed;
- Joshua, Anthony;
- Linette, Gerald;
- Gajewski, Thomas;
- Lutzky, Jose;
- Lawson, David;
- Lao, Christopher;
- Flynn, Patrick;
- Albertini, Mark;
- Sato, Takami
Publication type:
Article
Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment.
Published in:
2017
By:
- Vidisheva, Aleksandra;
- Wang, James;
- Spektor, Tanya;
- Bitran, Jacob;
- Lutzky, Jose;
- Tabbara, Imad;
- Ye, Joseph;
- Ailawadhi, Sikander;
- Stampleman, Laura;
- Steis, Ronald;
- Moezi, Mehdi;
- Swift, Regina;
- Maluso, Tina;
- Udd, Kyle;
- Eshaghian, Shahrooz;
- Nassir, Youram;
- Berenson, James;
- Vidisheva, Aleksandra P;
- Spektor, Tanya M;
- Bitran, Jacob D
Publication type:
journal article
Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.
Published in:
2021
By:
- Ribas, Antoni;
- Algazi, Alain;
- Ascierto, Paolo A.;
- Butler, Marcus O.;
- Chandra, Sunandana;
- Gordon, Michael;
- Hernandez-Aya, Leonel;
- Lawrence, Donald;
- Lutzky, Jose;
- Miller Jr, Wilson H.;
- Campbell, Katie M.;
- Delafont, Bruno;
- Marshall, Shannon;
- Mueller, Nancy;
- Robert, Caroline
Publication type:
Correction Notice
Impact of Medicaid Expansion Status and Race on Metastatic Disease at Diagnosis in Patients with Melanoma.
Published in:
Journal of Racial & Ethnic Health Disparities, 2022, v. 9, n. 6, p. 2291, doi. 10.1007/s40615-021-01166-6
By:
- Fabregas, Jesus C.;
- Carter, Benjamin T.;
- Lutzky, Jose;
- Robinson III, William Russell;
- Brant, Jeannine M.
Publication type:
Article
ASO Visual Abstract: Omission of Completion Lymph Node Dissection in Sentinel Node Biopsy Positive Head and Neck Cutaneous Melanoma Patients.
Published in:
2023
By:
- Kesmodel, Susan B.;
- Kronenfeld, Joshua P.;
- Zhao, Wei;
- Koru-Sengul, Tulay;
- Goel, Neha;
- Weingrad, Daniel N.;
- Hernandez-Aya, Leonel;
- Lutzky, Jose;
- Feun, Lynn;
- Garland-Kledzik, Mary;
- Crystal, Jessica S.
Publication type:
Abstract
Omission of Completion Lymph Node Dissection in Sentinel Node Biopsy Positive Head and Neck Cutaneous Melanoma Patients.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 12, p. 7671, doi. 10.1245/s10434-023-14036-8
By:
- Kesmodel, Susan B.;
- Kronenfeld, Joshua P.;
- Zhao, Wei;
- Koru-Sengul, Tulay;
- Goel, Neha;
- Weingrad, Daniel N.;
- Hernandez-Aya, Leonel;
- Lutzky, Jose;
- Feun, Lynn;
- Garland-Kledzik, Mary;
- Crystal, Jessica S.
Publication type:
Article
A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma.
Published in:
Investigational New Drugs, 2006, v. 24, n. 1, p. 89, doi. 10.1007/s10637-005-4544-y
By:
- Karl Lewis;
- John Thompson;
- Jeffrey Weber;
- William Robinson;
- Steven O'Day;
- Jose Lutzky;
- Sewa Legha;
- Simon Floret;
- Francis Ruvuna;
- Rene Gonzalez
Publication type:
Article
Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma.
Published in:
Cancer (0008543X), 2000, v. 88, n. 3, p. 557, doi. 10.1002/(SICI)1097-0142(20000201)88:3<557::AID-CNCR10>3.0.CO;2-5
By:
- Lilenbaum, Rogerio;
- Cano, Roberto;
- Schwartz, Michael;
- Siegel, Leonard;
- Lutzky, Jose;
- Lewis, Mark;
- Krill, Elisa;
- Barreras, Luis;
- Davila, Enrique
Publication type:
Article
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205.
Published in:
Science Translational Medicine, 2014, v. 6, n. 232, p. 1, doi. 10.1126/scitranslmed.3008068
By:
- Dhodapkar, Madhav V.;
- Sznol, Mario;
- Biwei Zhao;
- Ding Wang;
- Carvajal, Richard D.;
- Keohan, Mary L.;
- Ellen Chuang;
- Sanborn, Rachel E.;
- Lutzky, Jose;
- Powderly, John;
- Kluger, Harriet;
- Tejwani, Sheela;
- Green, Jennifer;
- Ramakrishna, Venky;
- Crocker, Andrea;
- Vitale, Laura;
- Yellin, Michael;
- Davis, Thomas;
- Keler, Tibor
Publication type:
Article
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases.
Published in:
NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00471-z
By:
- In, Gino K.;
- Ribeiro, Jennifer R.;
- Yin, Jun;
- Xiu, Joanne;
- Bustos, Matias A.;
- Ito, Fumito;
- Chow, Frances;
- Zada, Gabriel;
- Hwang, Lindsay;
- Salama, April K. S.;
- Park, Soo J.;
- Moser, Justin C.;
- Darabi, Sourat;
- Domingo-Musibay, Evidio;
- Ascierto, Maria L.;
- Margolin, Kim;
- Lutzky, Jose;
- Gibney, Geoffrey T.;
- Atkins, Michael B.;
- Izar, Benjamin
Publication type:
Article
Ipilimumab was safe and effective in two patients with metastatic melanoma and end-stage renal disease.
Published in:
Cancer Management & Research, 2015, v. 7, p. 47, doi. 10.2147/CMAR.S73389
By:
- Cavalcante, Ludimila;
- Amin, Asim;
- Lutzky, Jose
Publication type:
Article
Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series.
Published in:
2020
By:
- Holbrook, Kourtney;
- Lutzky, Jose;
- Davies, Michael A.;
- Davis, Jessica Michaud;
- Glitza, Isabella C.;
- Amaria, Rodabe N.;
- Diab, Adi;
- Patel, Sapna P.;
- Amin, Asim;
- Tawbi, Hussein
Publication type:
journal article
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.
Published in:
2019
By:
- Ott, Patrick A.;
- Pavlick, Anna C.;
- Johnson, Douglas B.;
- Hart, Lowell L.;
- Infante, Jeffrey R.;
- Luke, Jason J.;
- Lutzky, Jose;
- Rothschild, Neal E.;
- Spitler, Lynn E.;
- Cowey, C. Lance;
- Alizadeh, Aaron R.;
- Salama, April K.;
- He, Yi;
- Hawthorne, Thomas R.;
- Bagley, Rebecca G.;
- Zhang, Joshua;
- Turner, Christopher D.;
- Hamid, Omid
Publication type:
journal article
Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma.
Published in:
British Journal of Haematology, 2009, v. 146, n. 6, p. 619, doi. 10.1111/j.1365-2141.2009.07803.x
By:
- Jagannath, Sundar;
- Durie, Brian G. M.;
- Wolf, Jeffrey Lee;
- Camacho, Elber S.;
- Irwin, David;
- Lutzky, Jose;
- McKinley, Marti;
- Potts, Phyllis;
- Gabayan, Afshin Eli;
- Mazumder, Amitabha;
- Crowley, John;
- Vescio, Robert
Publication type:
Article
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.
Published in:
British Journal of Haematology, 2006, v. 135, n. 2, p. 174, doi. 10.1111/j.1365-2141.2006.06280.x
By:
- Berenson, James R.;
- Boccia, Ralph;
- Siegel, David;
- Bozdech, Marek;
- Bessudo, Alberto;
- Stadtmauer, Edward;
- Pomeroy, J. Talisman;
- Steis, Ronald;
- Flam, Marshall;
- Lutzky, Jose;
- Jilani, Syed;
- Volk, Joseph;
- Wong, Siu-Fun;
- Moss, Robert;
- Patel, Ravi;
- Ferretti, Delina;
- Russell, Kit;
- Louie, Robert;
- Yeh, Howard S.;
- Swift, Regina A.
Publication type:
Article
Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma.
Published in:
British Journal of Haematology, 2005, v. 129, n. 6, p. 776, doi. 10.1111/j.1365-2141.2005.05540.x
By:
- Jagannath, Sundar;
- Durie, Brian G. M.;
- Wolf, Jeffrey;
- Camacho, Elber;
- Irwin, David;
- Lutzky, Jose;
- McKinley, Marti;
- Gabayan, Eli;
- Mazumder, Amitabha;
- Schenkein, David;
- Crowley, John
Publication type:
Article
Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program.
Published in:
Oncologist, 2018, v. 23, n. 2, p. 193, doi. 10.1634/theoncologist.2017-0413
By:
- Sartor, Oliver;
- Vogelzang, Nicholas J.;
- Sweeney, Christopher;
- Fernandez, Daniel C.;
- Almeida, Fabio;
- Iagaru, Andrei;
- Brown Jr., Alan;
- Smith, Matthew R.;
- Agrawal, Manish;
- Dicker, Adam P.;
- Garcia, Jorge A.;
- Lutzky, Jose;
- Wong, Yu‐Ning;
- Petrenciuc, Oana;
- Gratt, Jeremy;
- Shore, Neal D.;
- Morris, Michael J.;
- for the U.S. Expanded Access Program Investigators
Publication type:
Article
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.976837
By:
- Khan, Shaheer;
- Lutzky, Jose;
- Shoushtari, Alexander N.;
- Jeter, Joanne;
- Marr, Brian;
- Olencki, Thomas E.;
- Cebulla, Colleen M.;
- Abdel-Rahman, Mohamed;
- Harbour, J. William;
- Sender, Naomi;
- Nesson, Alexandra;
- Singh-Kandah, Shahnaz;
- Hernandez, Susana;
- King, Jeanelle;
- Katari, Manpreet S.;
- Dimapanat, Lyssa;
- Izard, Stephanie;
- Ambrosini, Grazia;
- Surriga, Oliver;
- Rai, Alex J.
Publication type:
Article
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.
Published in:
2014
By:
- Carvajal, Richard D;
- Sosman, Jeffrey A;
- Quevedo, Jorge Fernando;
- Milhem, Mohammed M;
- Joshua, Anthony M;
- Kudchadkar, Ragini R;
- Linette, Gerald P;
- Gajewski, Thomas F;
- Lutzky, Jose;
- Lawson, David H;
- Lao, Christopher D;
- Flynn, Patrick J;
- Albertini, Mark R;
- Sato, Takami;
- Lewis, Karl;
- Doyle, Austin;
- Ancell, Kristin;
- Panageas, Katherine S;
- Bluth, Mark;
- Hedvat, Cyrus
Publication type:
journal article
Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma.
Published in:
JAMA: Journal of the American Medical Association, 2014, v. 311, n. 23, p. 2397, doi. 10.1001/jama.2014.6096
By:
- Carvajal, Richard D.;
- Sosman, Jeffrey A.;
- Quevedo, Jorge Fernando;
- Milhem, Mohammed M.;
- Joshua, Anthony M.;
- Kudchadkar, Ragini R.;
- Linette, Gerald P.;
- Gajewski, Thomas F.;
- Lutzky, Jose;
- Lawson, David H.;
- Lao, Christopher D.;
- Flynn, Patrick J.;
- Albertini, Mark R.;
- Sato, Takami;
- Lewis, Karl;
- Doyle, Austin;
- Ancell, Kristin;
- Panageas, Katherine S.;
- Bluth, Mark;
- Hedvat, Cyrus
Publication type:
Article
KIT as a Therapeutic Target in Metastatic Melanoma.
Published in:
JAMA: Journal of the American Medical Association, 2011, v. 305, n. 22, p. 2327, doi. 10.1001/jama.2011.746
By:
- Carvajal, Richard D.;
- Antonescu, Cristins R.;
- Wolchok, Jedd D.;
- Chapman, Paul B.;
- Roman, Ruth-Ann;
- Teitcher, Jerrold;
- Panageas, Katherine S.;
- Busam, Klaus J.;
- Chmielowski, Bartosz;
- Lutzky, Jose;
- Pavlick, Anna C.;
- Fusco, Anne;
- Cane, Lauren;
- Takebe, Naoko;
- Vemula, Swapna;
- Bouvier, Nancy;
- Bastian, Boris C.;
- Schwartz, Gary K.
Publication type:
Article
Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation.
Published in:
2008
By:
- Lutzky, Jose;
- Bauer, Juergen;
- Bastian, Boris C.
Publication type:
Letter
PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.
Published in:
Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-19810-w
By:
- Ribas, Antoni;
- Algazi, Alain;
- Ascierto, Paolo A.;
- Butler, Marcus O.;
- Chandra, Sunandana;
- Gordon, Michael;
- Hernandez-Aya, Leonel;
- Lawrence, Donald;
- Lutzky, Jose;
- Miller, Wilson H.;
- Campbell, Katie M.;
- Delafont, Bruno;
- Marshall, Shannon;
- Mueller, Nancy;
- Robert, Caroline
Publication type:
Article

Found: 24